jibi to rinsho
Online ISSN : 2185-1034
Print ISSN : 0447-7227
ISSN-L : 0447-7227
Clinical Studies of Fluticasone Propionate Aqueous Nasal Spray (3rd Report)
A Study in Vasomotor Rhinitis
Minoru OKUDATokuji UNNOYoshihisa SASAKIHiroshi TOMITAShunkichi BABAToru MATSUNAGAYukio INUYAMASatoshi FUKUDAAkikatsu KATAURAKoji ASAKURATadashi KOJIMAMitsuaki TAKAHASHINaoki HATAYAMAAkira NAKAMURAOsamu YANAINobuo SAKAMOTOJiro HOZAWAAtsushi MATSUBARATomonori TAKASAKANaoki INAMURAJun-ichi SATAKEKotaro BABAHitoshi SHIMADAJiro MUTOShigeru OMACHIToshio ISHIZAKAAkira SAITOTetsuzo INOUEManabu NAKANOBOYasuo TANAKAHitoshi KIYONOShun-ichi TOMIYAMAAkinori MEZAWAAkiyoshi KONNOYosuke FUJITATakayuki YAMAKOSHIMasaki ONISHIMasakazu IKEDAHideaki KOYAMAKumiko YAMADAKaoru SATOKyozo KIKUCHIKiyoshi MAKIYAMAKenji OKAZAKIYasuya NOMURAMasahiro MIZUNOHarumi SUZAKIYozo SAITOTetsuo ISHIIMidori NABESHIMAIchiyo KUBOTAYoshio HONDATomohiko ENDONobuo USUIKoichi ITOHiroshi OGAWAKazuhiro HASHIGUCHITetsuya SHITARAHirosato MIYAKEAtsushi SHINKAWAHideshige KIMURAYasuo HATTORIMasako KAJIMOTOIsamu TAKEYAMAKeisuke UESUGIHiroyuki ZUSHOShuju SAWAKISeiichiro YUYAMAYuichi NAKANOMasuo YAMAGISHIHitoshi SAITOShigeharu FUJIEDAShigehito MORIHiroshi YAJIMAYasuyuki NAGASHIMAAtsushi USAMINoriyuki YANAGITATsutomu NAKASIMAToru SUZUKIJoh NISHIMURAAkira YOKOTAHiromi ITOYasuhiko OYAHaruo ITOJun-ichiro SHIMADAShigenobu IWATAAkihiko TAKASUNobuo TAKEDAYasuo SAKAKURAKotaro UKAISawako MASUDAYasushi MURAKAMIHiroshi TAKENAKAKenji SAITOSatoshi KUMAZAWATadami KUMAZAWANobuo KAWAMURAShigeki OGINOYoshikiyo SAKAGUCHIKeizo MORIMATSUJun-ichi YOSHIDAMichihiro NOSEOsamu SENBAYoshiaki NAKAIYoshihiro OHASHIHirokazu SAKAMOTOToshihide TABATAJun-ichi YODAMutsuo AMATSUHaruhiko ISHIDAHirofumi MIYAKEYasuo HARADAKatsuhiro HIRAKAWAKazuhiko KUSAKAHisaaki IKOMATakeo SUZUKIGoro MOGIHideyuki KAWAUCHIAtsuo CHAENTakeru ISHIKAWAKeisuke MASUYAMAYasuaki SADANAGAMasaru OYAMAYasuhiro MIYAZAKIMasahiko EGAWA
Author information
JOURNAL FREE ACCESS

1993 Volume 39 Issue 1 Pages 49-65

Details
Abstract
To evaluate its clinical efficacy and safety, Fluticasone Propionate Aqueous Nasal Spray (FP ANS) was administered to 79 patients with vasomotor rhinitis in the dose of 200mcg/day for at least 2 weeks in principle (One received for 21 weeks). The following results were obtained. 1. In the assessment of final overall improvement, cases judged as “markedly improved” or “moderately improved” accounted for 72.7%, and the cumulative rate including “slightly improved” cases was 92.7%. 2. An adverse reaction, mild palpitation, occurred in 1 case. No abnormality was observed in the clinical laboratory test values. Based on the above results, FP ANS was confirmed to be an effective and safe drug for the treatment of vasomotor rhinitis.
Content from these authors
© JIBI TO RINSHO KAI
Previous article Next article
feedback
Top